We are glad to share that Neuranix was there in Hannover to present the PLAI™ (Pressure Less Acoustic Immittance) methodology for the first time in such an important Conference!
We had the opportunity to explain and present better our innovative PLAI™ patented technology for the evaluation of the status of the eardrum and the functionality of the middle ear, this generated a great interest and curiosity for its innovative concept among industy professionals.
Easy for the doctor, Easy for the patient!
The presentation about the PLAI™ generated a great interest in the audience!
For more information, please contact firstname.lastname@example.org
Within the POR – “Investment for growth and employment” objective FESR part European Regional Development Fund 2014-2020 ASSE Axis 1 ACTION 1.4.1. “Call for grants to innovative start-ups” Neuranix SRL is the beneficiary of a public contribution of € 120,000 as co-financing for the consolidation of the innovative start-up to achieve the objectives through highly specialized consultancy:
1) start the best phase of the innovative industrialisation in order to guarantee the maximum technical and commercial competitiveness of the new product;
2) the best go to market strategy thanks to a timely and complete market analysis, commercial and marketing strategies.
Structuring and analysis of commercial potential, drawing up of the business and financial plan for the definition of the best business strategy both from an economic / financial and marketing point of view.
Neuranix is admitted to the Campania NewSteel incubator program (CNS) – incubator certified under the Growth Decree 2.0 – promoted by Città della Scienza and the University of Naples Federico II. CNS builds further on the twenty-year experience of Città della Scienza on the creation of businesses – Best Science Based Incubator in Europe in 2008 and support for the creation of about 150 companies – with the research infrastructure, excellent skills and great capacity to produce talent and innovation of Federico II. For Neuranix, CNS enables the company to connect with technological and business development opportunities, as well as the main national structures supporting the development of our innovative start-up.
Development of a diagnostic device for the clinical-audiometric investigation of middle ear pathologies.
– a subsidized loan, with no interest, in the form of the repayable grant, of a maximum amount of € 532,000.00 (of which € 106,400.00 not subject to reimbursement), equal to 70% of the eligible expenses for the realization of the investment programs presented;
– a subsidized loan, without interest, in the form of the repayable grant, of a maximum amount of € 350,000.00 (of which € 70,000.00 is not subject to reimbursement), equal to 70% of the eligible operating costs.
Cap.Soc. 11.549,77 €
Registro imprese di Napoli NA-971341